VOYA Investment Management
CTKB icon

VOYA Investment Management’s Cytek Biosciences CTKB Stock Holding History

VOYA Investment Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Sell
74,034
-67,351
-48% -$288K ﹤0.01% 2018
2026
Q1 		$618K Buy
141,385
+43,555
+45% +$206K ﹤0.01% 1638
2025
Q4 		$494K Sell
97,830
-18,184
-16% -$84.4K ﹤0.01% 1760
2025
Q3 		$403K Buy
116,014
+77,702
+203% +$292K ﹤0.01% 1865
2025
Q2 		$130K Sell
38,312
-41,954
-52% -$140K ﹤0.01% 2423
2025
Q1 		$322K Buy
80,266
+40,517
+102% +$210K ﹤0.01% 2082
2024
Q4 		$258K Sell
39,749
-3,547
-8% -$21.1K ﹤0.01% 2275
2024
Q3 		$240K Buy
43,296
+1,679
+4% +$9.52K ﹤0.01% 2383
2024
Q2 		$232K Buy
41,617
+1,397
+3% +$8.39K ﹤0.01% 2394
2024
Q1 		$270K Sell
40,220
-9,241
-19% -$73.1K ﹤0.01% 2305
2023
Q4 		$451K Buy
49,461
+839
+2% +$5.28K ﹤0.01% 2130
2023
Q3 		$268K Sell
48,622
-262
-0.5% -$2.1K ﹤0.01% 2363
2023
Q2 		$417K Sell
48,884
-156,859
-76% -$1.41M ﹤0.01% 2192
2023
Q1 		$1.89M Buy
205,743
+45,390
+28% +$488K ﹤0.01% 1377
2022
Q4 		$1.64M Buy
160,353
+27,647
+21% +$372K ﹤0.01% 1416
2022
Q3 		$1.95M Buy
132,706
+89,829
+210% +$1.17M ﹤0.01% 1330
2022
Q2 		$460K Buy
+42,877
New +$427K ﹤0.01% 1886

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VOYA Investment Management's CTKB Position: Q2 2026 in Review

VOYA Investment Management reduced its Cytek Biosciences (CTKB) stake by 48% in Q2 2026, selling an estimated $288K and leaving 74,034 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

VOYA Investment Management first reported a position in CTKB in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.95M in Q3 2022. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • VOYA Investment Management held 74,034 shares of Cytek Biosciences worth $328K as of Q2 2026.
  • VOYA Investment Management sold 67,351 Cytek Biosciences shares in Q2 2026, an estimated $288K.
  • Cytek Biosciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2018 holding.
  • VOYA Investment Management first reported a position in Cytek Biosciences in Q2 2022 and has held it in 17 quarters since.
  • VOYA Investment Management's Cytek Biosciences position peaked at $1.95M in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.